Wealthcare Advisory Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,588
| Closed | -$413K | – | 957 |
|
|
2024
Q4 | $413K | Sell |
4,588
-299
| -6% | -$26.9K | 0.01% | 621 |
|
|
2024
Q3 | $483K | Buy |
4,887
+1,260
| +35% | +$124K | 0.01% | 577 |
|
|
2024
Q2 | $336K | Buy |
3,627
+917
| +34% | +$85K | 0.01% | 643 |
|
|
2024
Q1 | $257K | Buy |
+2,710
| New | +$257K | 0.01% | 715 |
|
|
2023
Q3 | – | Sell |
-4,021
| Closed | -$335K | – | 748 |
|
|
2023
Q2 | $335K | Sell |
4,021
-1,185
| -23% | -$98.6K | 0.02% | 536 |
|
|
2023
Q1 | $397K | Buy |
5,206
+1,325
| +34% | +$101K | 0.02% | 516 |
|
|
2022
Q4 | $322K | Sell |
3,881
-7,214
| -65% | -$599K | 0.02% | 516 |
|
|
2022
Q3 | $880K | Buy |
+11,095
| New | +$880K | 0.05% | 255 |
|
|
2022
Q1 | – | Sell |
-3,385
| Closed | -$379K | – | 599 |
|
|
2021
Q4 | $379K | Buy |
+3,385
| New | +$379K | 0.02% | 384 |
|
|
2021
Q3 | – | Sell |
-2,392
| Closed | -$324K | – | 587 |
|
|
2021
Q2 | $324K | Buy |
2,392
+1,622
| +211% | +$220K | 0.02% | 407 |
|
|
2021
Q1 | $104K | Buy |
+770
| New | +$104K | 0.01% | 658 |
|
|
2020
Q3 | – | Sell |
-1,973
| Closed | -$221K | – | 372 |
|
|
2020
Q2 | $221K | Buy |
1,973
+1,652
| +515% | +$185K | 0.03% | 284 |
|
|
2020
Q1 | $25K | Buy |
321
+77
| +32% | +$6K | ﹤0.01% | 681 |
|
|
2019
Q4 | $23K | Buy |
+244
| New | +$23K | ﹤0.01% | 737 |
|
|
2019
Q2 | – | Sell |
-275
| Closed | -$25K | – | 1365 |
|
|
2019
Q1 | $25K | Sell |
275
-500
| -65% | -$45.5K | ﹤0.01% | 611 |
|
|
2018
Q4 | $56K | Hold |
775
| – | – | 0.01% | 410 |
|
|
2018
Q3 | $74K | Hold |
775
| – | – | 0.01% | 389 |
|
|
2018
Q2 | $74K | Buy |
775
+758
| +4,459% | +$72.4K | 0.01% | 384 |
|
|
2018
Q1 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 1041 |
|